Table 2. Race and sex as determinants of non-beneficial PEG tubes after stroke.
Crude | Adjusted* | |||||
---|---|---|---|---|---|---|
Variable | OR | 95% CI | p-value | OR | 95% CI | p-value |
Race | ||||||
White | 1.00 (ref) | 1.00 (ref) | ||||
Black | 2.85 | 2.55–3.17 | <0.001 | 1.85 | 1.62–2.12 | <0.001 |
Hispanic | 2.32 | 2.00–2.69 | <0.001 | 1.67 | 1.42–1.97 | <0.001 |
Asian/Pacific Islander | 1.66 | 1.30–2.12 | <0.001 | 1.46 | 1.08–1.98 | 0.014 |
Other | 2.16 | 1.76–2.65 | <0.001 | 1.76 | 1.34–2.30 | <0.001 |
All Minorities | 2.47 | 2.26–2.70 | <0.001 | 1.75 | 1.57–1.96 | <0.001 |
Sex | ||||||
Female | 1.00 (ref) | 1.00 (ref) | ||||
Male | 1.55 | 1.43–1.69 | <0.001 | 1.27 | 1.16–1.40 | <0.001 |
*Model adjusted for age, hospital teaching status, hospital bed size, hospital location, hospital region, and annual volume of stroke cases, discharge quarter, weekend admission status, modified Charlson Comorbidity Index, APR-DRG severity subclass, insurance status, median household income per patient’s ZIP code, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, peripheral vascular disease, congestive heart failure, atrial fibrillation, valvular disease, anemia, thrombocytopenia, alcohol abuse, drug abuse, chronic kidney disease, pneumonia, urinary tract infection, sepsis, gastrointestinal bleeding, deep vein thrombosis, and pulmonary embolism.